Thus, irisin is considered to play a therapeutic role in type 2 diabetes and obesity due to the thermogenic changes in white adipose tissue (Bostrom et al., 2012; Kelly, 2012; Villarroya, 2012). The gene discussed is FNDC5; the disease is obesity due to melanocortin 4 receptor deficiency.